Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010

Data on newly diagnosed HIV infections and HIV prevalence in 2005 to 2010 suggest falling infection rates in injecting drug users (IDUs) in the European Union (EU). However, recent increases in HIV and hepatitis C virus (HCV) infection rates in IDUs suggest increasing injecting risks in some countri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Euro surveillance : bulletin européen sur les maladies transmissibles 2011-12, Vol.16 (48), p.9
Hauptverfasser:	Wiessing, L, Likatavicius, G, Hedrich, D, Guarita, B, van de Laar, M J, Vicente, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Disease prevention Drug use Europe - epidemiology European Union Health risk assessment Hepacivirus - pathogenicity Hepatitis Hepatitis C Hepatitis C - diagnosis Hepatitis C - economics Hepatitis C - epidemiology Hepatitis C - prevention & control Hepatitis C - transmission Hepatitis C - virology HIV HIV - pathogenicity HIV Infections - diagnosis HIV Infections - economics HIV Infections - epidemiology HIV Infections - prevention & control HIV Infections - transmission HIV Infections - virology Human immunodeficiency virus Humans Injections Insurance Coverage Needle-Exchange Programs - economics Population Surveillance Prevalence Risk Factors Risk-Taking Substance Abuse, Intravenous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Data on newly diagnosed HIV infections and HIV prevalence in 2005 to 2010 suggest falling infection rates in injecting drug users (IDUs) in the European Union (EU). However, recent increases in HIV and hepatitis C virus (HCV) infection rates in IDUs suggest increasing injecting risks in some countries. The coverage of effective prevention measures has increased, but is still low in several countries. Overall the data suggest a continued risk of new outbreaks of HIV infection among IDUs.
ISSN:	1560-7917 1025-496X 1560-7917
DOI:	10.2807/ese.16.48.20031-en